ACL Digital completed the acquisition of Symbiance.

ACL Digital, a provider of digital product innovation and engineering services, completed the acquisition of Symbiance, a biotechnology company. Financial terms were not disclosed. "We are pleased to welcome Symbiance. The acquisition aligns with our growth strategy, enhancing our capabilities and delivering patient-centric, transformative solutions that exceed the standards of the life sciences industry. Together, we are positioned to accelerate innovation and drive operational efficiency for our clients. Moreover, ACL Digital's AI-powered offerings, combined with Symbiance's deep clinical research domain expertise, will enable us to meet the industry's AI transformation needs, empowering organizations to adopt intelligent, data-driven solutions that lead to improved outcomes," Ramandeep Singh, ACL Digital CEO.